Ambarella Inc: Form 10-K for the period ended Jan 31, 2019
Filed with the SEC on Mar 29, 2019 and accepted by EDGAR at Mar 29, 2019, 15:33 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2018-02-01 to 2019-01-31 | $227.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2018-02-01 to 2019-01-31 | $89.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2018-02-01 to 2019-01-31 | $138.1m | us-gaap:GrossProfit |
| Research and development | 12 months2018-02-01 to 2019-01-31 | $128.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2018-02-01 to 2019-01-31 | $50.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2018-02-01 to 2019-01-31 | −$40.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2018-02-01 to 2019-01-31 | −$4.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2018-02-01 to 2019-01-31 | −$30.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2018-02-01 to 2019-01-31 | −$0.93 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2018-02-01 to 2019-01-31 | −$0.93 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2018-02-01 to 2019-01-31 | 32,713,606 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2018-02-01 to 2019-01-31 | $24.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2018-02-01 to 2019-01-31 | $2.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2018-02-01 to 2019-01-31 | $99.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-01-31 | $194.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-01-31 | $409.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-01-31 | $466.9m | us-gaap:Assets |
| Current liabilities | At period end2019-01-31 | $39.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-01-31 | $47.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-01-31 | $419.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-19-010114. Last ingested by Listed: Oct 30, 2026, 13:39 ET. Listed shows no prices and gives no investment advice.